Amitiza and Respiratory disorder - a phase IV clinical study of FDA data

Summary:

Respiratory disorder is reported as a side effect among people who take Amitiza (lubiprostone), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Epinephrine, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Respiratory disorder when taking Amitiza. It is created by eHealthMe based on reports of 10,225 people who have side effects when taking Amitiza from the FDA, and is updated regularly.

What is Amitiza?

Amitiza has active ingredients of lubiprostone. It is often used in constipation. eHealthMe is studying from 10,567 Amitiza users. Check the latest studies of Amitiza.

What is Respiratory disorder?

Respiratory disorder (respiratory disease) is found to be associated with 1,540 drugs and 1,583 conditions by eHealthMe. Check the latest studies of Respiratory disorder.

On Jul, 15, 2026

10,225 people reported to have side effects when taking Amitiza.
Among them, 28 people (0.27%) have Respiratory disorder.

Could Amitiza cause Respiratory disorder?

Among these 28 people:

How long have people been on Amitiza when they have Respiratory disorder? *

What is the gender of people who have Respiratory disorder when taking Amitiza? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Respiratory disorder when taking Amitiza? *

What are other drugs people take besides Amitiza? *

What are other side effects people have besides Respiratory disorder? *

Sinusitis (inflammation of sinus): 11 people, 39.29%
Headache (pain in head): 9 people, 32.14%
Nausea And Vomiting: 9 people, 32.14%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 28.57%
Dyspnea (difficult or laboured breathing): 7 people, 25.00%
Muscle Spasms (muscle contraction): 6 people, 21.43%
Migraine (headache): 6 people, 21.43%
Asthma: 6 people, 21.43%
Chest Pain: 6 people, 21.43%
Upper Respiratory Tract Infection: 5 people, 17.86%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 10 people, 35.71%
Immune System Disorder: 5 people, 17.86%
Hereditary Angioedema (recurrent episodes of severe swelling): 5 people, 17.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.71%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 7.14%
Impaired Gastric Emptying: 1 person, 3.57%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.57%
Hyperkalemia (damage to or disease of the kidney): 1 person, 3.57%
Weight Decreased: 1 person, 3.57%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Amitiza and have Respiratory disorder?

- Check whether Respiratory disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amitiza:

Amitiza (10,567 reports)

Browse all side effects of Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory disorder:

Respiratory disorder (1,540 drugs)

Browse all the conditions that are associated with Respiratory disorder:

Respiratory disorder (1,583 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lubiprostone (the active ingredients of Amitiza) and Amitiza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.